BCIS ACI 2020: Treating Shock in 2020

Published: 07 March 2020

  • Views:

    Views Icon 76
  • Likes:

    Heart Icon 0

Overview

Full programme

  • Views:

    Views Icon 76
  • Likes:

    Heart Icon 0

Overview

This video series filmed at the BCIS ACI 2020 meeting features an expert panel who examine the issues around treating shock and PPCI, they discuss the treatment options and the future and consider if mechanical circulatory support can be used as a way forward.  

This video series was created in partnership with BCIS.

Educational Objectives

  • To consider the prevalence and burden of shock in contemporary practice
  • To review the literature and data around treatment for shock patients
  • To discuss best practice treatment strategy for shock patients
  • To debate whether dedicated centres could improve outcomes
  • To discuss upcoming clinical data that may improve decision making.

Series overview

Part 1

Prevalence of Shock and Outcomes in PPCI

Dr Bethan Freestone (Birmingham Heartlands Hospital, Birmingham, UK), chair of the roundtable, introduces the topic of cardiogenic shock. Professor Anthony Gershlick (University of Leicester, Leicester, UK) discusses the prevalence of the condition and viable treatment options.

1 session

  • Prevalence of shock and outcomes in PPCI

    Watch now

Part 2

How Should We Treat Shock?

Dr Bethan Freestone (Birmingham Heartlands Hospital, Birmingham, UK) poses the question: How would you treat your cardiogenic shock patient? Prof Keith Oldroyd (West of Scotland Regional Heart & Lung Centre and Golden Jubilee National Hospital, Glasgow, UK) discusses treatment options based on his experiences. Dr Farzin Fath-Ordoubadi (Manchester University NHS, Manchester, UK) reflects on the role of drug therapy. Prof Anthony Gershlick (University of Leicester, Leicester, UK) talks about the need for smart medicine.

1 session

Part 3

Is MCS the Way Forward?

Dr Bethan Freestone (Birmingham Heartlands Hospital, Birmingham, UK) invites the panel to discuss the pros and cons of mechanical support devices. Dr Farzin Fath-Ordoubadi (Manchester University NHS, Manchester, UK) discusses the available devices and choosing the right time to use them. Prof Keith Oldroyd (West of Scotland Regional Heart & Lung Centre and Golden Jubilee National Hospital, Glasgow, UK) and Prof Anthony Gershlick (University of Leicester, Leicester, UK) talk about the challenges of conducting cardiogenic shock trials and the need for established centres.

1 session

Part 4

What’s on the Horizon?

The panel concludes the roundtable with exploring what studies are needed to help decision making. Dr Farzin Fath-Ordoubadi (Manchester University NHS, Manchester, UK) talks about DanGer shock. Prof Anthony Gershlick (University of Leicester, Leicester, UK) shares his experiences with the EURO SHOCK trial. The study focuses on the early use of a mechanical support device (ECMO), that can support patients and their heart needs to recover from a severe heart attack.

1 session

Faculty biographies